Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Shares Outstanding (Diluted Average) (2016 - 2025)

Nu-Med Plus' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $73.4 million for Q4 2021.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed N/A to $73.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was $73.4 million, a N/A change, with the full-year FY2021 number at $73.4 million, changed N/A from a year prior.
  • Shares Outstanding (Diluted Average) hit $73.4 million in Q4 2021 for Nu-Med Plus, down from $79.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for NUMD hit a ceiling of $79.3 million in Q3 2021 and a floor of $37.6 million in Q1 2018.
  • Historically, Shares Outstanding (Diluted Average) has averaged $62.4 million across 3 years, with a median of $73.4 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 100.9% in 2017 and later crashed 50.36% in 2018.
  • Tracing NUMD's Shares Outstanding (Diluted Average) over 3 years: stood at $71.9 million in 2017, then plummeted by 41.85% to $41.8 million in 2018, then skyrocketed by 75.6% to $73.4 million in 2021.
  • Business Quant data shows Shares Outstanding (Diluted Average) for NUMD at $73.4 million in Q4 2021, $79.3 million in Q3 2021, and $79.3 million in Q2 2021.